BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 35751653)

  • 1. The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.
    Makaremi S; Asgarzadeh A; Kianfar H; Mohammadnia A; Asghariazar V; Safarzadeh E
    Inflamm Res; 2022 Aug; 71(7-8):923-947. PubMed ID: 35751653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
    Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
    J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
    Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J
    J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
    Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
    J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.
    Conti P; Ronconi G; Caraffa A; Gallenga CE; Ross R; Frydas I; Kritas SK
    J Biol Regul Homeost Agents; 2020 March-April,; 34(2):327-331. PubMed ID: 32171193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 infection: an overview on cytokine storm and related interventions.
    Montazersaheb S; Hosseiniyan Khatibi SM; Hejazi MS; Tarhriz V; Farjami A; Ghasemian Sorbeni F; Farahzadi R; Ghasemnejad T
    Virol J; 2022 May; 19(1):92. PubMed ID: 35619180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
    Yao Z; Zheng Z; Wu K; Junhua Z
    Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
    Hawerkamp HC; Dyer AH; Patil ND; McElheron M; O'Dowd N; O'Doherty L; Mhaonaigh AU; George AM; O'Halloran AM; Reddy C; Kenny RA; Little MA; Martin-Loeches I; Bergin C; Kennelly SP; Donnelly SC; Bourke NM; Long A; Sui J; Doherty DG; Conlon N; Cheallaigh CN; Fallon PG
    Front Immunol; 2023; 14():1170012. PubMed ID: 37063871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics.
    Abbasifard M; Khorramdelazad H
    Life Sci; 2020 Sep; 257():118097. PubMed ID: 32679148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and microRNAs in SARS-CoV-2: What do we know?
    Rarani FZ; Rashidi B; Jafari Najaf Abadi MH; Hamblin MR; Reza Hashemian SM; Mirzaei H
    Mol Ther Nucleic Acids; 2022 Sep; 29():219-242. PubMed ID: 35782361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
    Conti P; Younes A
    J Biol Regul Homeost Agents; 2020 March-April,; 34(2):339-343. PubMed ID: 32253888
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Mardi A; Meidaninikjeh S; Nikfarjam S; Majidi Zolbanin N; Jafari R
    Viral Immunol; 2021 Dec; 34(10):679-688. PubMed ID: 34882013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
    Darif D; Hammi I; Kihel A; El Idrissi Saik I; Guessous F; Akarid K
    Microb Pathog; 2021 Apr; 153():104799. PubMed ID: 33609650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting the storm: could novel anti-TNFα and anti-IL-6
    Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O
    Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.